How much funding has Ivy Natal raised?

Ivy Natal has raised $250K in total funding, most recently a Seed round.

Who are Ivy Natal's investors?

Ivy Natal's investors include IndieBio, SOSV.

Where is Ivy Natal headquartered?

Ivy Natal is headquartered in San Francisco, California, United States.

What industry is Ivy Natal in?

Ivy Natal operates in Biotech, Healthcare.

Ivy Natal

Unlocking human fertility

San Francisco, United States · Founded 2020 · $250K raised

Biotech

Healthcare

Headquarters: San Francisco, California
Employees: 1–10
Founded: 2020
Business Model: B2C

Website: ivynatal.com
Total Funding: $250K
Last Round: $250K SeedApr 2020
Rounds: 1

About

Ivy Natal is a San Francisco-based VC-backed biotech company developing in vitro gametogenesis (IVG) technology to enable women who cannot produce eggs — due to surgery, chemotherapy, age, or genetic conditions — to have genetic children. The process begins with a simple skin biopsy and directly reprograms skin cells into healthy egg cells, bypassing traditional IVF limitations. Long term, the platform aims to extend reproductive choice to same-sex couples and anyone facing infertility.

Summary

Ivy Natal is a Biotech company based in San Francisco, United States, founded in 2020. It has raised $250K in total across 1 round, most recently a $250K Seed round in Apr 2020. Investors include IndieBio and SOSV.

LinkedIn X (Twitter)